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Abstract. The assembly of fibronectin (FN) into a 
fibrillar matrix is a complex stepwise process that in- 
volves binding to integrin receptors as well as interac- 
tions between FN molecules. To follow the progression 
of matrix formation and determine the stages during 
which specific domains function, we have developed 
cell lines that lack an endogenous FN matrix but will 
form fibrils when provided with exogenous FN.  Re- 
combinant FNs (recFN) containing deletions of either 
the RGD cell-binding sequence (RGD-) or the first 
type III repeats (FNAIIII_7) including the IIIx FN bind- 
ing site were generated with the baculovirus insect cell 
expression system.  After addition to cells, recFN ma- 
trix assembly was monitored by indirect immunofluo- 
rescence and by insolubility in the detergent deoxycho- 
late (DOC).  In the absence of any native FN, FNAIIII_7 
was assembled into fibrils and was converted into 
DOC-insoluble matrix.  This process could be inhibited 
by the amino-terminal 70 kD fragment of FN, showing 
that FNAIIII_7 follows an assembly  pathway similar to 
FN.  The progression of FNAIIII_7 assembly differed 
from native FN in that the recFN became DOC-insolu- 
ble more quickly.  In contrast, RGD- recFNs were not 
formed into fibrils except when added in combination 
with native FN.  These results show that the RGD se- 
quence is essential for the initiation step but fibrils can 
form independently of the 1111_7 modules.  The altered 
rate of FNAIIII_7 assembly suggests that one function of 
the missing repeats might be to modulate an early stage 
of matrix formation. 
F 
mRONECTIN (FN) 1  is a multifunctional component of 
the  extracellular matrix  (for review  see  Mosher, 
1989; Hynes, 1990).  From within the matrix, FN in- 
teracts with cells to control cell adhesion, cytoskeletal or- 
ganization, and intracellular signaling. It also forms a struc- 
tural framework for cell migration, differentiation, cell--cell 
interactions, and deposition of other matrix proteins.  The 
importance of FN has been underscored by recent results 
with an FN-null mutation which result in embryonic le- 
thality in mice (George et al., 1993).  Moreover, while the 
loss of an FN matrix is characteristic of many tumorigenic 
cells,  restoration  of this matrix  can  suppress  the  trans- 
formed phenotype (Giancotti and Ruoslahti, 1990). 
Models for assembly of FN into a fibrillar matrix pro- 
pose a stepwise process initiated by binding to cell surface 
receptors  followed by assembly and reorganization into 
fibrils  (for reviews  see  McDonald,  1988; Mosher et  al., 
1992; Mosher, 1993).  As increasing amounts of FN bind to 
cells, dimeric FN is converted into a complex network of 
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fibrils  that  is  insoluble  in  the  detergent  deoxycholate 
(DOC) and consists of high molecular weight aggregates 
(Hynes and Destree, 1977; Keski-Oja et al., 1977; Choi and 
Hynes, 1979; McKeown-Longo and Mosher,  1983).  The 
a5131 integrin appears to be a major receptor for matrix as- 
sembly (Ruoslahti, 1991; Wu et al., 1993).  Antibodies that 
interfere with the interaction between e~5131 and the RGD 
site block this process (Akiyama et al., 1989; McDonald et 
al.,  1987; Roman  et  al.,  1989; Darribere  et  al.,  1990; 
Fogerty et al.,  1990).  Two other RGD-dependent inte- 
grins, odlb[33 and etv133, have also been shown to partici- 
pate (Wu et al., 1995c; Wennerberg et al., 1996) and may 
account for the observation that cells from a5 integrin null 
mice  are  able  to  assemble  an  FN  matrix  (Yang  et  al., 
1993).  A number of other integrins bind to FN but do not 
initiate fibril formation (Busk et al.,  1992; Zhang et al., 
1993;  Wu et  al.,  1995a).  The  absolute necessity of the 
RGD sequence has been brought into question with the 
observations that recFNs lacking RGD are incorporated 
into fibrils (Schwarzbauer,  1991) indicating that interac- 
tions with RGD might not be required at all stages of ma- 
trix formation. 
After binding to the cell surface, interactions occur be- 
tween FN molecules leading to the formation of fibrils. 
Several FN domains that contribute to this process have 
been identified.  The amino-terminal domain, particularly 
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bly (McKeown-Longo and Mosher, 1985; Quade and Mc- 
Donald, 1988; Schwarzbauer, 1991; Aguirre et al.,  1994). 
The carboxy-terminal cysteine pair that forms the covalent 
disulfide-bonded dimer is  also required, as only dimeric 
FN  becomes incorporated into  a  matrix (Schwarzbauer, 
1991; Sottile and Wiley, 1994).  In addition, a third region 
encompassing modules 19 and 1111 is involved. Monoclonal 
antibodies  against  this  region  inhibit  matrix  assembly 
(Chernousov  et  al.,  1988,  1991;  Darribere  et  al.,  1992). 
More recently, the III~ module has been shown to be a ma- 
jor  site  of FN-FN  binding  (Morla  and  Ruoslahti,  1992; 
Aguirre et al., 1994; Hocking et al., 1994) and is capable of 
inducing  the  formation  of disulfide  cross-linked  FN  in 
vitro (Morla et al., 1994).  This module is apparently not 
critical for fibril formation as a  recombinant FN lacking 
repeats 1111_7 was readily incorporated into a fibrillar ma- 
trix by SVT2 fibroblasts (Schwarzbauer, 1991).  We have 
designed an FN matrix assembly system based on cell lines 
that  are  capable  of assembling  exogenous recombinant 
FNs (recFNs) but lack their own endogenous matrix.  In 
contrast  to  the  SVT2  cell  system  previously  described 
(Schwarzbauer, 1991), this system is not complicated by 
the presence of normal endogenous FN.  As a result, the 
type and concentration of FN added to the system can be 
completely controlled and the progression of fibril forma- 
tion can be followed at specific time points after addition 
of FN.  We have found that a recFN lacking repeats IIIt_7 
(FNAIIII_7)  can be assembled into fibrils in the absence of 
native  FN  while  deletion  of the  RGD  cell-binding  se- 
quence abolishes fibril formation.  The ability of RGD- 
polypeptides to be incorporated when added along with 
native  FN  demonstrates  that  the  RGD  sequence  is  re- 
quired for initiation of matrix formation but is not needed 
in all incoming FN molecules incorporated at later steps. 
Differences in the rate of FNAIIII_7 assembly compared to 
native FN suggest that the 1111_7 region plays a regulatory 
role in the process. 
Materials and Methods 
Cell Culture 
Mouse AtT-20 pituitary cells were  transfected with human a5  integrin 
cDNA in a retroviral vector (Hynes et al., 1992) using Lipofectin reagent 
(Life  Technologies/GIBCO-BRL,  Gaithersburg,  MD).  G418-resistant 
clones were screened for expression of a5 integrin by adhesion to FN- 
coated surfaces.  Expression was confirmed by immunoprecipitation of 
metabolically labeled cell lysates (Marcantonio and Hynes, 1988).  Clone 
AtT-20c~5 No. 11 was used for all experiments described.  AtT-20~5 cells 
were grown in a 50:50 mixture of Ham's F12 and DMEM supplemented 
with 20 mM Hepes, pH 7.4, 4 mM L-glutamine, 10% Nu-serum (Collabo- 
rative Research, Bedford, MA), 10%  FCS (Hyclone Labs, Logan, UT), 
and 0.25 mg/ml Geneticin (Life Technologies/GIBCO-BRL). 
CHO-K1 cells were transfected by electroporation using 8  X 106 cells 
with 20 txg of a human a5 integrin cDNA in vector pBJ-1 (Lin et al., 1990) 
and 1 p.g of pFneo DNA containing a neomycin-resistance gene.  Trans- 
fected cells were maintained in DMEM supplemented with 10% FCS at 
37°C in 6% CO2 for 2 d, and then transferred to the same medium con- 
taining 100 i~g/ml G418 (Life Technologies/GIBCO-BRL) and harvested 
after 10-14 d of selection.  The expression level of ct5 integrin was con- 
firmed  by  flow  cytometric  analysis  in  FACScan  (Becton-Dickinson, 
Mountain View,  CA)  with monoclonal antibody  16  against human a5 
(Akiyama et al., 1989).  Clone CHOa5-17, used for all experiments, was 
obtained by single cell sorting of the G418-resistant cells with monoclonal 
antibody 16 in FACStar (Becton-Dickinson).  Monoclonal antibody PB1 
(Brown and Juliano, 1985) was used for detection of endogenous hamster 
cal.  The level of expression of human a5 was threefold higher than ham- 
ster a5.  Production of endogenous FN was detected by metabolic labeling 
of cells with [35S]methionine followed by immunoprecipitation with poly- 
clonal antibody R39 or gelatin binding of labeled medium as described 
(Schwarzbauer et al., 1989).  CHOct5 cells were maintained in DMEM, 
10% FCS (Hyclone Labs), 2 mM glutamine, 1% nonessential amino acids, 
and 100 ~g/ml Geneticin (Life Technologies/GIBCO-BRL). 
BTI-TN-5B1-4 (High Five) insect cell line (Invitrogen Corp., San Di- 
ego, CA) was maintained in TNM-FH (Grace's medium supplemented 
with  yeastolate  and  lactalbumin  hydrolysate)  supplemented with  10% 
FCS.  For purification of recombinant protein, High Five cells were grown 
in either Sf-900 II or Express Five serum-free medium (Life Technologies/ 
GIBCO-BRL). 
To prepare FN-depleted serum, fetal calf and Nu-serum were passed 
over a gelatin-agarose column two times as described (Engvall and Ruo- 
slahti, 1977) resulting in 99.7% depletion of FN.  The amount of flbronec- 
tin remaining in the FCS was calculated to be ~62 ng/ml, translating to 
6 ng,/ml in complete medium. 
FN cDNA Constructions 
Baculovirus vector pVL1392 was used for expression of all recombinant 
FNs (recFNs).  Restriction enzymes and T4 DNA ligase were purchased 
from New England Biolabs (Beverly, MA).  Construction of FNAIIII_7 
and 70 kD have been previously described (Schwarzbauer, 1991; Aguirre 
et al., 1994). 
Full-length recFN FNA-B- was created by digesting a rat FN cDNA 
spanning the region coding for 19 through 11111 with NheI-Rsrll.  The re- 
suiting 4,071-bp fragment was ligated to NheI-RsrlI digested pVL1392- 
FNAIIII_  7.  For FNAIII1_7(RGD-), a 2,215-bp RsrlI-StuI fragment iso- 
lated  from  pLJ-II_9/Cll0-RGDS  (Schwarzbauer,  1991)  was  ligated  to 
pVL1392-FNAIIIl_  7 which had been digested with RsrlI-StuI. From the 
resulting plasmid, a  1.6-kb Rsrll-SacI fragment was isolated and ligated 
to  RsrlI-SacI  digested  pVL1392-FNAIIIl_7  in  order  to  create  FNA- 
B-(RGO  ). 
Recombinant Protein Production and Purification 
Recombinant baculoviruses were  generated  by  cotransfection of  High 
Five cells with FN constructions in baculovirus vector pVL1392 and Bacu- 
logold DNA (Pharmingen, San Diego, CA).  Single viral clones were ob- 
tained by limiting dilution cloning of transfection supernatants. High titer 
stocks were amplified as described by Summers and Smith (1987). 
High Five cells grown in serum-free medium were infected with high ti- 
ter recombinant virus stock at an m.o.i, of 10.  Culture medium was col- 
lected 34  d postinfection.  PMSF (0.5  mM) and EDTA  (10 raM) were 
added  to  inhibit proteolysis.  Recombinant protein  and  rat  plasma FN 
(pFN) were purified by gelatin-agarose chromatography essentially as de- 
scribed by EngvaU and Ruoslahti (1977).  Recombinant protein prepara- 
tions were free of contaminating intact FN since High Five cells do not 
produce FN.  Purity of preparations was confirmed by silver stain analysis 
(Merril et al., 1984) and immunohlot after SDS-PAGE. 
Immunofluorescence 
Polyclonal  rabbit  anti-FN  antiserum R39  (Schwarzbauer  et  al.,  1989) 
which recognizes rat, hamster, bovine, and human FNs was used at a dilu- 
tion of 1:50.  Culture supernatant from hybridoma cells producing rat-spe- 
cific monoclonal antibody IC3  was diluted 1:10. 
AtT-20et5 and CHO~5 cells were seeded on glass coverslips in 24-well 
dish or Lab Tek Chamber Slides (Nunc Inc., Naperville, IL) at concentra- 
tions of 4 x  105 and 1.5 ×  105 cells/cm  2, respectively.  Cells were seeded in 
medium containing FN-depleted serum and incubated for ~24 h until cells 
were almost confluent.  AtT-20a5 cells were seeded into medium contain- 
ing FN-depleted 10% Nu serum/20% FCS.  Fresh medium, serum-free for 
short incubations or with FN-dcpleted serum for longer incubations, was 
then added along with pFN or recFNs and 70 kD as indicated.  At the end 
of the incubation period, cells were washed with PBS and fixed with 3.7% 
formaldehyde in PBS for 15 min at room temperature.  Coverslips were 
then washed with PBS and incubated with primary antisera diluted in 2% 
ovalbumin in PBS in a moist chamber at 37°C for 30 rain. 
Coverslips incubated with polyclonal antibody were washed with PBS 
and incubated with goat anti-rabbit biotinylated IgG (Life Technologies/ 
GIBCO-BRL)  at  a  1:100  dilution followed by  rhodamine-avidin (ICN 
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coverslips incubated with monoclonal antibodies were incubated with flu- 
orescein-conjugated goat anti-mouse IgG (Molecular Probes, Inc., Eu- 
gene, OR) at a dilution of 1:320. All coverslips were then washed for a fi- 
nal  time  and  mounted  with  FfTC-Guard  (Testog,  Inc.,  Chicago,  IL). 
Fibrils were visualized  with a Nikon Optiphot microscope with epifluores- 
cence using a 40x  phase/fluorescence or 60×  plan-apochromatic objec- 
tive.  Photography was performed as described in Schwarzbauer (1991). 
Isolation and Detection of DOC-soluble 
and -insoluble Material 
AtT-20a5 and CHOa5 cells were cultured in wells of a 24-well dish, in the 
absence of glass coverslips essentially as described above.  For inhibition 
experiments with the 70-kD fragment, cells were cultured in a 96-well tis- 
sue culture plate.  RecFNs or pFN were incubated with the cultured cells 
for defined periods of time.  At the end of the incubation period, the cell 
layers were washed with serum-free DMEM,  and  then lysed in 200  I~1 
deoxycholate (DOC) lysis buffer (2% deoxycholate, 0.02 M Tris-HCl, pH 
8.8, 2 mM PMSF, 2 mM EDTA, 2 mM iodoacetic acid, and 2 mM N-ethyl- 
maleimide) per well.  DOC-insoluble material was isolated by centrifuga- 
tion and then solubilized  in  1%  SDS, 25  mM Tris-HCl, pH 8.0, 2 mM 
PMSF, 2 mM EDTA, 2 mM iodoacetic acid, and 2 mM N-ethylmaleimide. 
Aliquots of DOC-soluble and insoluble material were electrophoresed on 
a 5% SDS polyacrylamide gel nonreduced and reduced with DqT. 
Proteins were transferred to nitrocellulose (Sartorius Corp., Bohemia, 
NY) for immunodetection by using a Mini-Protean II transfer apparatus 
(BioRad Labs, Hercules, CA) according to manufacturer's instructions. 
Filters were blocked overnight in buffer A  (25 mM "Iris HCI, pH 7.5, 150 
mM NaCI, 0.1% Tween-20) at room temperature.  IC3 hybridoma cell cul- 
ture supernatant was diluted I:100 in buffer A and incubated with the fil- 
ter for 1 h  at room temperature followed by three washes in buffer A. 
Biotinylated goat anti-mouse IgG (Life Technologies/GIBCO-BRL) was 
added at a 1:10,000 dilution in buffer A, incubated 1 h at room tempera- 
ture,  and  washed with buffer A.  A  1:10,000 dilution  of streptavadin- 
horseradish peroxidase (Life Technologies/GIBCO-BRL) was added, in- 
cubated 30 min at room temperature, and washed.  Immunoblots were 
then developed with chemiluminescent reagents (New England Nuclear 
Dupont, Boston, MA) according to instructions of the manufacturer and 
exposed to film (X-omat; Eastman Kodak Co., Rochester, NY). 
Quantitation of DOC-soluble and -insoluble Material 
DOC-soluble and -insoluble material was extracted from CHOa5 cells in- 
cubated with pFN or recFNs as described  above.  Total protein in the 
DOC-soluble and -insoluble fractions was measured by a BCA protein as- 
say (Pierce,  Rockford, IL) in order to standardize each of the collected 
samples.  Equal amounts of total protein from either DOC-insoluble or 
DOC-soluble fractions from various time points were reduced with DT]? 
and electrophoresed on a 5% SDS polyacrylamide gel.  Protein was trans- 
ferred to nitrocellulose as described above.  Filters were blocked over- 
night at room temperature with 5% BSA in TBS (50 mM Tris-HCl, 200 
mM NaC1). IC3 hybridoma culture supernatant was diluted 1:100 and in- 
cubated with the filter for I h at room temperature.  After three washes in 
TBS, the filter was incubated with rabbit anti-mouse IgG (Pierce) diluted 
to 1 ~g/ml in 5%  BSA in TBS for 1 h  at room temperature, and then 
washed three times with TBS.  Approximately 6 ixCi ~25I-Protein A (New 
England Nuclear Dupont) was then added to the filter in 10 ml 5% BSA 
in TBS.  The 125I-Protein A  was incubated with the blot for 1 h at room 
temperature and then washed four times with buffer A until background 
signal  was minimal.  Washed blots were exposed to a phosphor storage 
screen  and  analyzed  using  a  Molecular  Dynamics  PhosphorImager 
(Sunnyvale, CA).  Total cell-associated  FN for each of the six time points 
was calculated  as DOC-insoluble counts plus DOC-soluble counts.  DOC- 
insoluble and -soluble values were expressed in terms of percent of total 
cell-associated  FN. 
Results 
Fibronectin Matrix Assembly System 
Cell lines, lacking an endogenous FN matrix but capable 
of assembling a matrix when supplied with exogenous FN, 
were used to develop a matrix assembly system dependent 
on recombinant FNs  (recFNs).  The mouse pituitary cell 
line AtT-20 does not produce either the a5 integrin sub- 
unit or endogenous FN.  mRNAs were not detectable by 
Northern blot analysis (ct5) and reverse transcriptase PCR 
(FN).  The absence of protein was confirmed by immuno- 
precipitations with anti-et5 (data not shown) and anti-FN 
antibodies (Castle et al., 1995).  Transfection of these cells 
with human et5 cDNA in a retroviral vector resulted in ex- 
pression of the ct5 subunit and presentation at the cell sur- 
face as a  complex with  the  endogenous 131  subunit.  As 
they produce no endogenous FN, the AtT-20a5 cells ex- 
pressing the chimeric ct5131 FN receptor do not form a FN 
matrix (Fig. 1 A).  These cells are, however, capable of as- 
sembling exogenous rat plasma FN (pFN) into a fibrillar 
matrix.  When added to cell culture medium at 25 ~tg/ml, 
pFN accumulates in the form of fibrils at the cell surface as 
detected by immunofluorescence (Fig.  1 C).  At concen- 
trations below 25 ~g/ml, a sparser pattern of FN fibrils was 
observed (Fig. 1 B), with no apparent fibril formation be- 
low 5 ixg/ml.  At concentrations above 25 txg/ml, AtT-20a5 
cells  became less  adherent  and  detached  from the  sub- 
strate. 
The AtT-20a5 cell line provides a unique system for de- 
termining the activity of various FN domains during initia- 
tion of matrix assembly in the absence of any endogenous 
FN.  The fact that they become less adherent to substrate 
upon prolonged incubation with FN makes them less suit- 
able for examining the later steps of matrix formation.  For 
these  types  of studies  a  CHOa5  cell  line  generated  by 
transfection of human a5 cDNA into CHO-K1 cells was 
used.  This particular CHOct5 cell clone expresses a very 
low level of endogenous FN, which is insufficient to pro- 
duce an FN matrix as determined by immunofluorescence 
(Fig. 1 D) or by analysis of DOC-insoluble matrix even in 
the presence of recFNs (data not shown).  Like AtT-20a5 
cells,  CHOa5 cells are capable of assembling exogenous 
FN into a fibrillar network (Fig. 1, E  and F).  Incubation 
with 1 ~g/ml or 5 Ixg/ml of pFN over a 15-h time period re- 
sulted  in  no  detectable  FN  fibrils.  At  10  ixg/ml  sparse 
fibrils mostly limited  to  short  connections  between  cells 
were formed (Fig. 1 E).  A  network of fibrils became evi- 
dent with the addition of 25 ixg/ml and increased in density 
with 50 ~g/ml (Fig. 1 F).  CHOot5 cells remained adherent 
to substrate  even with  the  addition  of higher concentra- 
tions of FN and at prolonged incubation times. 
Use of the AtT-20a5 cells lacking endogenous FN pro- 
duction and the CHOa5 cells severely deficient in FN pro- 
duction provides a model system for investigating FN ma- 
trix assembly.  As neither cell line produces a preformed 
matrix, the  type and concentrations  of FN added  to the 
system can be controlled.  Therefore, the roles of specific 
FN domains during fibril formation as well as the progres- 
sion of matrix assembly can be dissected with this system. 
Production of  Recombinant FNs in a Baculovirus 
Expression System 
The large quantities  of recFNs  needed  for these  studies 
were expressed and purified using the baculovirus insect 
cell system.  Expression in insect cells allows for proper 
disulfide bond formation which is required for the forma- 
tion of FN dimers as well as folding of the type I and II re- 
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AtT-20ot5 (top) and  CHOet5 
cells (bottom). Cells were cul- 
tured in medium with FN-de- 
pleted  serum,  fixed,  and 
stained  with  a  polyclonal 
anti-FN  antibody  (A  and 
D).  No FN fibrils  were ob- 
served  for  either  AtT-20tx5 
(A)  or CHOa5  (D).  Back- 
ground  staining  of  cells  by 
rhodamine-avidin is visible in 
D.  Occasional  fibrils  were 
observed upon addition of 10 
i~g/ml rat pFN to culture me- 
dium  followed  by  staining 
with  a  rat-specific  mono- 
clonal  antibody IC3  (B  and 
E).  A more extensive fibril- 
lar matrix was observed upon 
the addition of 25  i~g/ml rat 
pFN  to  AtT-20et5  cells  (C) 
and  50  p,g/ml rat  pFN  to 
CHOa5 cells (F).  Bar equals 
10 i~m. 
peats.  Fig. 2 illustrates the recFNs expressed and purified 
from infected  insect  cell  culture  medium.  FNA-B-  is  a 
full-length  rat  FN,  lacking  only the  alternatively  spliced 
EIIIA and EIIIB regions.  FNAIIII_7 has an 80-kD internal 
deletion  of  repeats  1111_7 (referred  to  as  I1_9/Cl10  in 
Schwarzbauer, 1991).  In FNA-B-(RGD-)  and FNAIIII_7 
(RGD-), the RGDS cell-binding sequence in repeat III10 
has been deleted.  All of the recFNs contain the two car- 
boxy-terminal cysteines required for dimer formation and 
the alternatively spliced V120 region, which is required for 
efficient dimer secretion (Schwarzbauer et al., 1989).  All 
four recFNs were efficiently secreted from insect cells pri- 
marily as disulfide bonded dimers. 
A  RecFN Lacking Repeats 1111_7  Is Capable of 
Independent Fibril Formation 
Recombinant FNAIII~_7 is assembled into a fibrillar matrix 
when expressed in SVT2 fibroblasts (Schwarzbauer, 1991). 
However, since SVT2 cells produce low levels of endoge- 
nous FN, it was not possible to ascertain  whether  or not 
this  recFN  was capable  of independent  fibril  formation. 
FNAIIII_7  was  tested  for  assembly  by  AtT-20et5  and 
CHOet5 cells in order to address whether repeats IIIl_7 are 
required for this process.  Both AtT-20a5 cells (Fig. 3, A 
and  B)  and  CHOet5  cells  (Fig.  3,  C  and  D)  assembled 
FNAIII1_7 into fibrils.  These results  demonstrate  that re- 
peats  IIIl_7, including  the  FN-binding  site  in  repeat  III1, 
are not required for FN fibril formation in this system. 
As an FN matrix forms, dimeric FN at the cell surface is 
converted from a DOC-soluble form to one which is insol- 
uble.  A  proportion of this DOC-insoluble material exists 
as high molecular weight multimers  that remain either at 
the top of the stacking gel or penetrate the separating gel 
but  migrate  more  slowly  than  dimeric  FN under  nonre- 
duced conditions.  Exogenous pFN also becomes incorpo- 
rated  into  these  high  molecular  weight  aggregates  (Mc- 
Keown-Longo and Mosher, 1983).  To determine whether 
FNAIIII_7 can be incorporated into a DOC-insoluble ma- 
trix,  DOC-soluble  and  -insoluble  material  was  isolated 
from AtT-20a5 and CHOet5 cells ~15 h  after addition to 
the culture medium.  As shown in Fig. 4, both cell lines as- 
sembled FNAIIII_  7 into matrix-associated, DOC-insoluble 
material.  High molecular weight multimers  of FNAIIII_7 
were present at the top of the stacking gel and at the inter- 
face of the stacking and separating gel.  These aggregates 
were  not  present  upon  reduction  of  insoluble  material 
(data not shown) or in nonreduced soluble fractions (Fig. 4). 
High molecular  weight  DOC-insoluble  material  was not 
Figure 2.  Schematic representation of FN and recFNs expressed 
in the baculovirus insect cell system.  The structural organization 
of FN is shown at the top. The three types of repeats which com- 
prise the FN molecule are indicated as: type I (open rectangles), 
type II (triangles), and type III (stippled ovals). Darkened ovals 
represent the alternatively spliced EIIIA and EIIIB repeats, nei- 
ther of which was included in any of the recombinants. The V120 
variant of the alternatively spliced V region (cross hatch box) was 
used for all recombinants. Location of the carboxy-terminal cy- 
tesine  pair required  for FN dimer formation is indicated  (SS). 
Each of the four recombinants was constructed from rat FN cD- 
NAs. A solid triangle is used to indicate deletion of the RGDS se- 
quence in repeat 11110. RecFNs FNA-B- and FNA-B-(RGD-) 
are  full-length  FNs.  RecFNs  FNAIIII_7 and  FNAIIII_7(RGD-) 
contain and internal 80-kD deletion of repeats III1_7. 
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20ct5 (top panel) and CHOet5 (bottom panel) cells were incubated 
for 15 h in serum-free medium containing 25 l~g/ml FNAIIII_7  for 
AtT-20et5 cells (A and B) or 50 I~g/ml FNAIIII_7  for CHOct5 cells 
(C and  D).  Fibrils were  detected  by indirect  immunofluores- 
cence using rat-specific monoclonal  antibody  IC3 and  fluores- 
cein-conjugated goat anti-mouse  IgG.  Bar equals 10 ixm. 
present in the purified protein or after overnight incuba- 
tion in the absence of cells (not shown).  These data show 
the formation of fibrils or the incorporation of these fibrils 
into DOC-insoluble high molecular weight multimers can 
occur independent of repeats III1_7. 
Progression of Fibril Formation 
A  major advantage of this system is that it allows one to 
follow the de novo formation of an FN matrix at specific 
time points after the addition of FN to cells.  Fig. 5 illus- 
trates the time course of fibril formation by CHOa5 cells 
for  rat  pFN  as  well  as  the  two  recFNs,  FNA-B-  and 
FNAIIII_7. At the 30-min time point, binding of FN to the 
periphery  of the  cells  was  observed  for  all  three  FNs. 
Fibril formation by FNA-B- was virtually identical to that 
of rat pFN.  Within 1 h of incubation, FN accumulated at 
the  cell  surface  and  resulted  in  the  formation  of short 
fibrils between cells.  A fibrillar network formed by 3 h of 
incubation and increased in density over time. 
While the organization of FNAIIII_7  at the cell surface 
was very similar to the other FNs at 30 min, as more pro- 
tein accumulated a  different pattern  of FNAIIII_7 matrix 
was observed (Fig. 5).  Rather than the formation of dis- 
tinct fibrils,  as was characteristic of pFN and FNA-B-, flu- 
orescent aggregates appeared on the cell surface.  By 24 h 
many of the  aggregates had  been  remodeled into fibrils 
that  extended  from  one  cell  to  another  and  appeared 
somewhat thicker than native FN fibrils.  By 48 h, a com- 
plex network of fibrils had formed.  Therefore, FNAIIII_  7 
fibrils  developed over a  significantly longer time  frame, 
taking greater than 12 h longer to form a fibrillar network 
than full-length FN. 
Figure  4.  Analysis  of  DOC-soluble  and  -insoluble material. 
DOC-soluble  and  -insoluble material  was  isolated  from  AtT- 
20et5 and CHOet5 cells incubated for 15 h with 25 I~g/ml  or 50 Ixg/ 
ml FNAIIII_7,  respectively.  DOC-soluble  (S) and -insoluble (/) 
fractions were separated  by 5%  SDS-PAGE without reduction 
and transferred to nitrocellulose. FN was detected with a rat-spe- 
cific monoclonal antibody IC3 and chemiluminescence reagents. 
360-kD dimeric FNAIIII_7  is present  in  all fractions  (open ar- 
rows). High molecular weight multimers of FNAIII~_  7 are present 
at the top of the stacking gel and at the interface of stacking and 
separating gels from insoluble fractions only (solid arrows). Mo- 
lecular mass standards of 180 and 116 kD are marked by dashes 
on the left. 
FNAIIII_7Is Incorporated into DOC-insoluble Material 
More Rapidly than pFN 
FNAIIII_7 associates rapidly with cells followed by gradual 
assembly into  fibrils.  To determine  the  stage  at  which 
FNAIIII_  7  is  incorporated  into  DOC-insoluble  matrix, 
DOC-soluble and -insoluble fractions were isolated from 
CHOet5  cells  incubated  with  either  pFN,  FNA-B-,  or 
FNAIIII_7.  All three FNs accumulated as cell-associated 
DOC-soluble  material  that  was  subsequently  converted 
into  DOC-insoluble  matrix  (Fig.  6).  DOC-soluble FNs 
were associated with cells  at all time points (right panels). 
High molecular weight, disulfide-stabilized aggregates char- 
acteristic of an insoluble matrix increased with time in non- 
reduced samples  from  all  three  matrices  (middle panels). 
These high molecular weight multimers were not present 
in DOC-soluble material.  Compared to pFN, significantly 
more FNA-B- and FNAIIII_7 were insoluble by 4 h after 
addition.  Furthermore, analysis of DOC-insoluble protein 
under  reducing conditions suggests  that  FNAIIII_7 accu- 
mulates  more  rapidly  in  this  fraction  than  either  full- 
length FN (leflpanels). 
Quantitation  of  DOC-soluble  and  -insoluble  FN  re- 
vealed a marked difference in the rate of matrix formation 
between  FNAIIII_  7  and  full-length  FN  (Fig.  7).  First, 
DOC-insoluble  material  appeared  much  faster  with 
FNAIIII_7. Second, the amount of insoluble FNAIIII_  7 reached 
Sechler et al. Fibronectin  Matrix  Assembly  577 Figure 5.  Immunofluorescence analysis of fibril formation at increasing times. Rat pFN (top), FN(A-B-) (middle), and FNAIIII_7  (bot- 
tom) were added to CHOa5 cells at a concentration of 50 Izg/ml. Cells were fixed, stained with rat-specific monoclonal antibody IC3, and 
visualized by immunofluorescence.  Rat pFN and FNA-B- were incubated with cells for 0.5, 1, 3, and 15 h (boxed numbers). FNAIIII_7 
incubations were 0.5, 4, 24, and 48 h as indicated. 
maximal amounts  (70%  of total  cell-associated FN)  be- 
tween 4 and 7 h of incubation.  In contrast, DOC-insoluble 
material  from  rat  pFN  and  FNA-B-  reached  maximal 
amounts  between 7 and 15 h and represented at least 90% 
of the total cell-associated FN,  These results demonstrate 
an alteration in the timing of the FN matrix assembly pro- 
cess indicating  that  the  region  lacking in  FNAIIII_7 may 
play a role in the temporal regulation of fibril formation. 
Matrix  formation with  FNA-B-  also  differed  slightly 
from rat pFN (Fig. 7).  The appearance of DOC-insoluble 
material  occurred  more  quickly  for  FNA-B-  than  rat 
pFN, although not nearly to the extent of FNAIIII_7.  The 
most notable structural difference between FNA-B- and 
pFN  is  in  the  alternatively  spliced  V  region.  FNA-B- 
consists  of  V120-V120  homodimers  while  pFN  consists 
primarily of V÷-V0 heterodimers. 
pFN and both recFNs formed disulfide-bonded high mo- 
lecular weight multimers.  However, at the 15-h time point, 
the  percentage  of FNAIIII_7 in  the  multimeric form ap- 
peared somewhat less than either pFN or FNA-B- (Fig. 6). 
Reduced accumulation of insoluble multimers might par- 
allel the slower rate of fibril formation by FNAIIII_7.  To 
test  this  possibility,  FNAIII~_  7 and  pFN  were  incubated 
with CHOa5 cells for 48 h  followed by analysis of equal 
amounts of DOC-insoluble material.  As shown in Fig. 8 A, 
the proportion of FNAIIII_7 in the form of high molecular 
weight multimers was equivalent to that of pFN. 
FNAIIII_7 Assembly Is Inhibited by Excess 70 kD 
Fibronectin interactions involving the amino-terminal do- 
main are essential for matrix assembly.  Inhibition of these 
interactions by inclusion of excess 70 kD fragment or anti- 
bodies against this  region  disrupts  the  assembly process 
(McKeown-Longo  and  Mosher,  1985;  McDonald  et  al., 
1987; Quade and McDonald, 1988). To determine whether 
FNAIIII_7 is assembled by the same mechanism as FN, we 
tested whether the addition of 70 kD fragment could in- 
hibit fibril formation.  Increasing concentrations of 70 kD 
fragment caused similar reductions in the amount of DOC- 
insoluble  material  formed  by  both  pFN  and  FNAIIII_7 
(Fig. 8 B).  In addition, fewer fibrils were detected in cul- 
tures incubated with pFN or FNAIIII_7 plus 70 kD (Fig. 9). 
Therefore,  similar  types  of  interactions  involving  the 
amino-terminal region are  used in  the  assembly of both 
FNAIIII_7 and pFN.  These results also show that the ag- 
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DOC-insoluble matrix. DOC-soluble and -insoluble material was 
isolated from CHOet5 ceils after incubation  with rat pFN (top), 
FNA-B-  (middle), or FNAIIII_7 (bottom) for 0.5, 4,  and  15  h. 
DOC-insoluble (reduced and nonreduced)  and soluble  (nonre- 
duced) fractions were separated by 5% SDS-PAGE and FN was 
detected as in Fig. 4.  Dimeric FN and recFN (open arrows) accu- 
mulate in DOC-insoluble fractions  with  time.  High molecular 
weight multimers are present at the top of the stacking gel and in- 
terface of stacking and separating gels of nonreduced DOC-insol- 
ubte material from all three FNs (solid  arrows). Positions of mo- 
lecular mass standards of 180 and 116 kD are marked by dashes 
on the left. 
gregation of FNAIII~_7 observed early in the assembly pro- 
cess involves specific interactions between FN molecules. 
RecFNs Lacking RGD Cannot Support 
Matrix Formation 
Antibody  blocking  experiments  have  demonstrated  the 
importance  of aS~I/RGD  interaction  for matrix  forma- 
tion (McDonald et aI., 1987; Akiyama et al., 1989; Roman 
et  al.,  1989;  Darribere  et  al.,  1990;  Fogerty et  al.,  1990). 
However, a  recFN  lacking  RGD  (II_9/Cl10-RGDS)  was 
fully capable of fibril formation when expressed in SVT2 
fibroblasts  (Schwarzbauer,  1991).  Two  recFNs  lacking 
RGD,  FNAIIII_7(RGD-),  and  FNA-B-(RGD-)  were 
tested  for  their  ability  to  independently  support  matrix 
formation.  Addition of each of these recFNs to CHOet5 
cells resulted only in the binding of FN to the periphery of 
the cells, principally at regions of cell-cell contact (Fig. 10, 
A  and C).  A  fibrillar network was never formed from ei- 
ther of the two proteins, even when added at high concen- 
trations (up to 75 Izg/ml).  Additions of as much as 50 I~g/ 
ml of FNA-B-(RGD-)  to AtT-20ct5 cells resulted in no 
detectable fibril formation and no localization to areas of 
cell-cell contact as observed with CHOct5 cells (Fig. 10 E). 
In addition,  neither  DOC-soluble nor -insoluble FN was 
detected from cell lysates with either recFN(RGD-) (data 
not  shown).  Deletion  of the  RGD from FNAIIII_7 abol- 
ished the ability of this recFN to become incorporated into 
either DOC-insoluble aggregates or a  fibrillar form dem- 
onstrating that FNAIIII_7 matrix assembly requires specific 
interactions with the cell surface. 
To determine whether the RGD sequence is required at 
all stages of assembly, native FN was included in the incu- 
bation.  In the presence of human pFN,  both FNAIIII_7 
(RGD-)  and  FNA-B-(RGD-)  were  incorporated  into 
DOC-insoluble material (data not shown) and into fibrils 
as detected by indirect immunofluorescence using a mono- 
clonal antibody specific for rat FN (Fig. 10, B, D, and F). 
Thus RGD- recFNs are capable of fibril formation in the 
presence of native FN.  Human pFN was only required to 
initiate the process of assembly.  CHOa5 cells incubated 
with human pFN for 3 h, washed, and incubated for an ad- 
ditional  14  h  with  fresh  medium  containing  only FNA- 
B-(RGD-) formed a  recFN matrix similar to that in Fig. 
10 D.  Therefore, the RGD sequence is required for the 
initiation of matrix formation but is not essential in all in- 
coming FN  molecules  added  at  later  steps  during  fibril 
elongation. 
Discussion 
In this report, we have described an FN matrix assembly 
system based on cell lines that  are capable of forming a 
fibrillar matrix solely from exogenous FN. A  major advan- 
tage of this system is the ability to dissect the independent 
assembly of recFNs from the earliest stages of binding to 
cells.  In addition, the progression of fibril formation can 
be analyzed at specific time points  after addition  of FN, 
making it possible to determine the stages at which certain 
FN domains function.  These cell lines assemble a  recFN 
lacking repeats IIIl_7 into a matrix, and, like native FN, as- 
sembly is dependent on both the 70-kD region and RGD 
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Figure 7.  Rate of incorpora- 
tion  of pFN,  FNA-B-,  and 
FNAIII~_7 into  DOC-insolu- 
ble matrix.  Quantitative im- 
munoblot  analysis  was  per- 
formed on DOC-soluble and 
-insoluble  cell  extracts  iso- 
lated  from CHOet5  cells  in- 
cubated  with  each  of  the 
three FNs over the indicated 
periods of time as described 
under  Materials  and  Meth- 
ods.  Values are expressed in 
terms of percentage of total cell-associated FN (DOC-soluble plus insoluble) at each time point.  In each case, DOC-soluble material 
(closed circles) is converted into DOC-insoluble matrix (open circles). 
sequence.  Differences in the rate of its assembly suggest 
that the deleted region plays a regulatory role during fibril 
formation. 
Within  the  first  seven  type  III repeats  reside  a  major 
FN-binding  site  in  the  Illl  module  and  two  low  affinity 
heparin-binding  regions  in  repeat  1111 and  repeats  1114_6 
(Hynes, 1990).  The FN-binding site appears to be cryptic 
(Morla  and  Ruoslahti,  1992;  Hocking  et  al.,  1994)  but, 
when exposed, it is able to interact with the first five type I 
repeats  (Aguirre et  al.,  1994; Hocking et al.,  1994).  FN- 
FN interactions involving Illl or other as yet unidentified 
sites  within  repeats  1111_  7 could play a  role  in regulating 
matrix assembly.  We have postulated that intramolecular 
interactions  between FN-binding sites in 11_5 and 1111 do- 
mains  could hold  soluble  FN  dimers  in  a  compact form 
that is inactive for assembly (Aguirre et al., 1994).  Confor- 
mational transitions in FN upon binding to the cell surface 
could  disrupt  the  intramolecular  interactions,  activating 
FN by making the binding sites in 11-5 and Illl available for 
association with adjacent FN dimers.  Removal of one of 
the binding sites,  as in FNAIIII_7, might yield a  constitu- 
tively active molecule that behaves differently during the 
first stages of assembly.  Our data fit well with this model. 
FNAIIII_7 becomes DOC-insoluble significantly faster than 
full-length FN after  binding to ct5131 on the  cell surface. 
The increased rate of accumulation suggests that FNAIII1_7 
is already in an activated state. 
Figure 8.  Characterization of DOC-insoluble matrix.  (A) CHOa5 
cells were incubated with medium containing 50 ixg/ml FNAIIII_7 
or rat pFN for 48 h.  DOC-insoluble material was isolated and 
equal amounts of total protein were analyzed by SDS-PAGE un- 
der nonreduced conditions.  FN was detected with IC3 antibody 
and chemiluminescence reagents.  High molecular weight multi- 
mers (solid arrows) and dimeric FN (open arrows) are indicated. 
(B) CHOet5 cells were incubated with medium containing 25 p~g/ 
ml FNAIIII_7 or rat pFN and 0, 50, or 100 ~g/ml 70 kD fragment 
for 16 h.  DOC-insoluble material was isolated and FN detected 
under reduced conditions as described above.  Position of 180 kD 
molecular mass standard is indicated by dash. 
Figure 9.  Inhibition of fibril formation with the 70-kD amino-ter- 
minal fragment.  CHOa5 cells were incubated with 50 wg/ml rat 
pFN (A and B) or FNAIIII_7 (C and D) for 16 h followed by stain- 
ing for immunofluorescence.  In B and D, ~1 mg/ml 70 kD frag- 
ment was included in the incubation.7 
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the RGD sequence.  CHOo~5  or AtT-20a5 cells were incubated 
with medium containing 50 p,g/ml FNAIIII_7(RGD-) or FNA- 
B-(RGD-) for 16 h  followed by staining for immunofluores- 
cence (A, C, and E).  In B, D, and F, cells were incubated with a 
mixture of 25 p,g/ml human  pFN plus 25 ~g/ml recFN(RGD-) 
and stained with monoclonal antibody IC3 which detects only the 
rat recFNs. Bar equals 10 I~m. 
A  requirement for activation of FN in order for assem- 
bly to proceed adds another step to the complex process of 
matrix assembly.  Our model for the major steps is illus- 
trated in Fig.  11.  Compact soluble FN binds to ot5131 or 
other integrin receptors.  This  activates the molecule by 
dissociating the intramolecular interactions near the amino 
terminus and exposing the FN-binding sites.  These sites 
can then participate in FN-FN interactions thus initiating 
fibril formation.  As more FN dimers bind and integrins 
cluster, the local accumulation of FN results in fibril for- 
mation and DOC-insolubility.  The matrix then becomes 
stabilized  into  high  molecular  weight  disulfide-bonded 
multimers.  There appear to be at least two mechanisms 
for assembly into fibrils,  one involving integrins at the cell 
surface  and  another  involving interactions  with  existing 
FN fibrils.  The latter pathway would be the primary route 
of RGD-recFN assembly.  Fragment  inhibition  experi- 
ments  also  support  the  existence  of  two  mechanisms. 
Fragments containing either the amino-terminal 70 kD or 
the central cell-binding domain can inhibit FN binding to 
Figure 11.  Model for fibronectin  matrix assembly. Dimeric fi- 
bronectin is secreted from the ceil in an inactive form.  Intramo- 
lecular interactions  between  FN-binding sites such as the  first 
type III repeats and I1_5 prevent interactions with other FN mole- 
cules (top).  The binding of compact soluble FN to an activated 
integrin  receptor  triggers a  conformational  change  and  subse- 
quent  release  of amino-terminal  binding  sites which are  then 
available for intermolecular  interactions  and  initiation  of fibril 
formation (middle).  As integrins cluster and the local concentra- 
tion  of cell-associated FN molecules increases, disulfide cross- 
linking and fibril elongation occur (bottom). 
cell surfaces and thus prevent matrix assembly (McDonald 
et al., 1987; this report).  In contrast, fragments containing 
1111 cannot inhibit the initial interactions of FN at the cell 
surface  and  do not block de  novo assembly (Morla  and 
Ruoslahti, 1992).  However, 1111 fragments can inhibit FN 
incorporation into an established matrix (Chernousov et al., 
1991;  Morla  and  Ruoslahti,  1992).  Inhibition of distinct 
steps illustrates the sequential nature of the assembly pro- 
cess.  Perhaps different domains and interactions can dom- 
inate depending on the site and stage of assembly. 
Binding of an activated FNAIIII_7 allows the FNs to skip 
the activation step and proceed more quickly to the next 
step.  Without proper tethering of both ends of the fibrils, 
they could collapse into  aggregates that must  be  subse- 
quently remodeled and stretched into fibrils.  The in vivo 
formation of FNAIIII_7 fibrils  might be  similar  to the  in 
vitro process reported by Morla et al. (1994).  In their ex- 
periments,  FN incubated  with  a  fragment of repeat  III1 
formed DOC-insoluble aggregates that contained fibrillar 
structures visible only after stretching.  The DOC-insolu- 
ble FNAIIII_7 is not completely fibrillar during the  early 
stages of assembly but it can be subsequently remodeled 
into fibrils.  This remodeling takes longer than native FN 
fibril formation indicating that the 1111_7 region plays a role 
Sechler et al. Fibronectin Matrix Assembly  581 in coordinating fibrillogenesis with conversion into DOC- 
insoluble matrix possibly by regulating the rate of activa- 
tion of FN at the cell surface.  It seems unlikely that the 
rate of assembly is affected by the length of this recFN be- 
cause inclusion  of low levels of native FN were  able to 
modulate  the  progression of assembly.  When FNAIIII_7 
(RGD-) was added to cells along with human pFN, recFN 
fibril assembly proceeded normally and no cell-associated 
aggregates were detected by immunofluorescence even at 
early times (Sechler, J.L., and J.E. Schwarzbauer, unpub- 
lished observations).  In addition, no aggregates were ob- 
served when FNAIIlI_7 was expressed in SVT2 fibroblasts 
(Schwarzbauer, 1991). 
Changes  in  activation state  have been clearly demon- 
strated for integrin receptors (for review see Ginsberg et al., 
1992)  and represent an important regulatory mechanism. 
Cells  expressing low affinity receptors  do not  adhere  to 
ligand while those in the high affinity or activated state are 
able to bind ligand effectively.  Faull et al. (1993) have pos- 
tulated  that  the  activation  state  of a5131  integrin  might 
play an important role in FN fibrillogenesis.  This is sup- 
ported by the observation that osteosarcoma cells stimu- 
lated with lysophosphatidic acid exhibit enhanced binding 
of FN  (Zhang  et  al.,  1994).  More  recently it  has  been 
shown that the cdlb133 integrin supports matrix assembly 
only when in an activated state (Wu et al.,  1995c).  We 
propose that the activation of the FN ligand also plays a 
regulatory role in fibril formation.  When assembly is re- 
quired,  inactive  FN  may  bind  to  an  activated  receptor 
which in turn leads to activation of the FN molecule.  The 
dual requirement for activated integrin and activated FN 
may provide two check points to assure that a  matrix is 
formed only at the appropriate time and place. 
While  a  recFN lacking 1111_7 can initiate fibrillogenesis 
independent of full-length FN, recFNs lacking an RGD se- 
quence cannot.  Neither AtT-20a5 nor CHO~x5 cells were 
capable of assembling RGD-FNs into DOC-insoluble ma- 
terial.  Indirect immunofluorescence of AtT-20a5 cells in- 
cubated  with  FNA-B-(RGD-)  showed  no  detectable 
fibrils.  However, CHOck5 cells localized a small amount of 
this recFN to regions of cell-cell contact.  The different 
uses of FNA-B-(RGD-) between the two cell types could 
be due to interactions with the very low level of FN pro- 
duced by CHOa5 cells.  However, the CHO FN was not 
detected  in  DOC-insoluble  matrix  formed by FNAIII>7 
and low levels of pFN) (< 5 ixg/ml) were unable to cause 
either RGD-recFN to be detected at the cell surface or in 
DOC-insoluble  material  when  added  to  AtT-20a5  cells 
(Sechler, J.L., and J.E. Schwarzbauer, unpublished obser- 
vations).  It seems more likely that RGD-recFNs may be 
interacting  with  receptors  or  other  proteins  present  on 
CHOa5 ceils but not on AtT-20~x5 cells.  For example, Wu 
et  al.  (1995b)  have implicated c~3131 and  entactin  in  the 
deposition of FN into a matrix by CHO cells in a mecha- 
nism  which  is  independent  of RGD.  Therefore,  while 
a5131 binding to the RGD sequence appears to be the ma- 
jor mechanism for assembly, other routes are possible. 
Although essential, the presence of the RGD sequence 
is only required during the initial stage of assembly. Prein- 
cubation of cells with native human pFN provided suffi- 
cient  nucleation  sites  for  subsequent  incorporation  of 
RGD-recFNs.  These results demonstrate that FN assem- 
bly involves RGD-dependent and -independent phases.  It 
is also likely that other regions of FN influence matrix for- 
mation.  For example, FNA-B-  which consists of V120- 
V120 homodimers was able to assemble into DOC-insolu- 
ble material at a slightly faster rate than V+-V0 pFN.  The 
V  region apparently has weak FN-binding activity (Agu- 
irre et al., 1994) which could give V120-V120 homodimers 
a  slight advantage in fibril formation or alignment.  It is 
therefore possible that alternative splicing of FN may pro- 
vide a mechanism to modulate matrix assembly. 
In  summary,  our  results  demonstrate  differential  re- 
quirements for the RGD sequence and the first type III re- 
peats during FN matrix assembly.  RGD-dependent inter- 
actions with 0t5131 are required to initiate assembly in this 
system.  In contrast, the first type III repeats apparently 
play a role in regulating the conversion to DOC-insolubil- 
ity and the rate of fibril formation. 
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